News Vaxxas announces CEPI partnership to advance needle-free mRN... Biotech Vaxxas has announced a partnership agreement with the 2017-established Coalition for Epidem
R&D Keeping the pandemic at bay with needle-free vaccine deliver... COVID-19 is still circulating and there are fears that further spikes in cases are to be expected in the coming months.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.